Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study
Condition(s):SchizophreniaLast Updated:March 8, 2018Completed
Hide Studies Not Open or Pending
Condition(s):SchizophreniaLast Updated:March 8, 2018Completed
Condition(s):Schizophrenias; Psychoses; Psychotic Disorders; Schizophrenic DisordersLast Updated:May 19, 2006Completed
Condition(s):Health Behavior; AgingLast Updated:October 9, 2018Unknown status
Condition(s):Chronic DiseaseLast Updated:May 13, 2015Completed
Condition(s):Transfemoral AmputationLast Updated:December 26, 2019Completed
Condition(s):Mild Obstructive Sleep Apnea SyndromeLast Updated:November 13, 2019Completed
Condition(s):Multiple SclerosisLast Updated:April 25, 2017Withdrawn
Condition(s):DepressionLast Updated:October 4, 2023Recruiting
Condition(s):Stroke Sequelae; Motor Skills DisordersLast Updated:November 1, 2023Not yet recruiting
Condition(s):MemoryLast Updated:July 25, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.